Scarica l'app Stockscreener
139.71
0.42%
-0.59
Dopo l'orario di chiusura:
139.89
0.18
+0.13%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GILD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Gilead Sciences Inc Borsa (GILD) Ultime notizie
Kelleher Financial Advisors Increases Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Meridian Investment Counsel Inc. Has $3.94 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Perpetual Ltd Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets - finance.yahoo.com
Gilead Sciences, Inc. (GILD) Galapagos NV,M&A CallSlideshow (NASDAQ:GILD) 2026-04-03 - Seeking Alpha
Gilead Sciences, Inc. $GILD Position Reduced by Aberdeen Group plc - MarketBeat
Layoff Tracker: Gilead Lays Off Employees at California Headquarters - BioSpace
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review - Ad Age
Gilead Sciences, Inc. (GILD.NE) recent insider transactions - Yahoo Finance UK
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - finance.yahoo.com
Gilead Refuses to Sell Groundbreaking HIV Prevention Drug to MSF - MarketScreener
HF Advisory Group LLC Buys 13,212 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
MSF Seeks Access to Breakthrough HIV Drug, But Gilead Refuses - allAfrica.com
Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF - allAfrica.com
A Healthy Return: Drug Spin-off Nets Keymed Up To $320M - Benzinga
Bank Pictet & Cie Europe AG Purchases 136,605 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Banque Pictet & Cie SA Purchases 142,543 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Allspring Global Investments Holdings LLC Purchases 71,872 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
Nomura VIP Core Equity Series's Gilead Sciences Inc(GILD) Holding History - GuruFocus
Gilead to acquire Ouro Medicines in $2.18B deal, expand inflammation pipeline - MSN
Morgan Stanley Reaffirms Overweight on Gilead Sciences, Inc. (GILD), Citing LEN Potential - MSN
Gilead extends Arcellx tender offer expiration date - MSN
Gilead (NASDAQ: ACLX) extends $115 per‑share tender, CVR pays $5 on condition - Stock Titan
Gilead Extends Tender Offer to Acquire Arcellx - Business Wire
Gilead Sciences Supports the LGBTQ+ Community in Oakland: Love Is the Answer - ACCESS Newswire
Gilead Sciences's Q1 2026 Earnings: What to Expect - Barchart
Gilead Sciences Inc Stock (GILD) Moved Up by 3.03% on Apr 1: Facts Behind the Movement - TradingKey
Gilead Sciences, Inc. $GILD Shares Acquired by Moody Lynn & Lieberson LLC - MarketBeat
Gilead Sciences, Inc. $GILD Stock Holdings Raised by Nisa Investment Advisors LLC - MarketBeat
Meyer Handelman Co. Has $41.33 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Shrier Wealth Management LLC Buys Shares of 14,244 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing - finance.yahoo.com
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution - FinancialContent
Gilead Sciences Inc. stock rises Tuesday, still underperforms market - MarketWatch
Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $160 - Moomoo
UBS reiterates Gilead Sciences stock rating on strong Yeztugo sales - Investing.com
Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis - TradingKey
Gilead and its new HIV prevention drug are in the sights of a well-known humanitarian group - The Business Journals
MSF denied access to Gilead HIV-prevention drug - EU Reporter
J. Safra Sarasin Holding AG Trims Gilead Sciences Stake - National Today
Gilead (GILD) Enters Agreement to Acquire Ouro Medicines - GuruFocus
Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V. - MarketBeat
Boston Common Asset Management LLC Sells 15,833 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration - finance.yahoo.com
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - The Manila Times
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Biotech deal-O-rama, Gilead and Tallon’s U.K. vision — a BioCentury podcast - biocentury.com
[Press release] Médecins Sans Frontières: Gilead refuses to sell groundbreaking HIV prevention drug to MSF - European AIDS Treatment Group
Gilead Sciences (NASDAQ: GILD) CEO sells 10,000 shares under 10b5-1 plan - Stock Titan
Gilead Sciences Inc. stock outperforms competitors on strong trading day - MarketWatch
Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization - statnews.com
Gilead refuses to sell groundbreaking HIV prevention drug to MSF - MSF Access
Open letter to Gilead: Prevention should not be a privilege - Doctors Without Borders
Beacon Investment Advisory Services Inc. Buys 10,449 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences Sees Surge in Institutional Investment - National Today
Gilead Sciences, Inc. $GILD Stake Lifted by USA Financial Formulas - MarketBeat
Wedge Capital Management L L P NC Reduces Stock Position in Gilead Sciences, Inc. $GILD - MarketBeat
Synergy Asset Management LLC Has $204,000 Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Exchange Traded Concepts Boosts Gilead Sciences Stake - National Today
Exchange Traded Concepts LLC Raises Position in Gilead Sciences, Inc. $GILD - marketbeat.com
Gilead Sciences: Caution After A Re-Rating Amidst New Concentration Risks (NASDAQ:GILD) - Seeking Alpha
List of 20 Acquisitions by Gilead (Mar 2026) - Tracxn
Why Gilead Sciences (GILD) Dipped More Than Broader Market Today - Yahoo Finance
1.37%
0.81%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):